✓ Dissolves fibrin clots (blood clots)
✓ Improved blood circulation
✓ Cardiovascular & Arterial health
Human clinical studies have demonstrated the ability of nattokinase to decrease euglobin (clot) lysis time (ELT) up to 8 hours after oral intake of a dose of natto estimated at 6,000 fibrin degradation units (FU). In addition, euglobulin fibrinolytic activity (EFA; lysis area on a fibrin plate) was increased significantly up to 12 hours following administration.
NSK-SD™ is a superior form of Nattokinase